Attached files
file | filename |
---|---|
EXCEL - IDEA: XBRL DOCUMENT - IMMUNE PHARMACEUTICALS INC | Financial_Report.xls |
EX-31.1 - EXHIBIT 31.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex31-1.htm |
EX-31.2 - EXHIBIT 31.2 - IMMUNE PHARMACEUTICALS INC | v405335_ex31-2.htm |
EX-32.1 - EXHIBIT 32.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex32-1.htm |
EX-23.1 - EXHIBIT 23.1 - IMMUNE PHARMACEUTICALS INC | v405335_ex23-1.htm |
EX-10.42 - EXHIBIT 10.42 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-42.htm |
EX-10.38 - EXHIBIT 10.38 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-38.htm |
EX-10.41 - EXHIBIT 10.41 - IMMUNE PHARMACEUTICALS INC | v405335_ex10-41.htm |
10-K - FORM 10-K - IMMUNE PHARMACEUTICALS INC | v405335_10k.htm |
EX-32.2 - EXHIBIT 32.2 - IMMUNE PHARMACEUTICALS INC | v405335_ex32-2.htm |
Exhibit 21.1
Subsidiaries of Immune Pharmaceuticals Inc.
The following are the subsidiaries of Immune Pharmaceuticals Inc.:
Name | Jurisdiction of Incorporation | |
Immune Pharmaceuticals USA Corp. | Delaware | |
Immune Pharmaceuticals Ltd. | Israel | |
Maxim Pharmaceuticals, Inc. | Delaware | |
Cytovia, Inc. | Delaware | |
EpiCept GmbH (in liquidation) | Germany |